{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:33:33Z","timestamp":1775558013123,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ecl.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T18:48:07Z","timestamp":1525978087000},"page":"313-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Mortality in Patients with Endogenous Cushing\u2019s Syndrome"],"prefix":"10.1016","volume":"47","author":[{"given":"Pedram","family":"Javanmard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza B.","family":"Geer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ecl.2018.02.005_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","article-title":"Cushing\u2019s syndrome","volume":"37","author":"Pivonello","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9522","key":"10.1016\/j.ecl.2018.02.005_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2018.02.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing\u2019s syndrome","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing\u2019s disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00268-007-9387-6","article-title":"Surgery for Cushing\u2019s syndrome: an historical review and recent ten-year experience","volume":"32","author":"Porterfield","year":"2008","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.005_bib8","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2018.02.005_bib10","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1550-8528.1994.tb00097.x","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932","volume":"2","author":"Cushing","year":"1994","journal-title":"Obes Res"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","article-title":"The natural history of Cushing\u2019s syndrome","volume":"13","author":"Plotz","year":"1952","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2018.02.005_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000315813","article-title":"Mortality in Cushing\u2019s disease","volume":"92","author":"Clayton","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.005_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.005_bib15","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.005_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing\u2019s syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing\u2019s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.005_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing\u2019s syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing\u2019s disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib22","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","article-title":"Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements","volume":"89","author":"Biermasz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.005_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing\u2019s syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.005_bib25","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib26","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","article-title":"Outcome of Cushing\u2019s disease following transsphenoidal surgery in a single center over 20 years","volume":"97","author":"Hassan-Smith","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib27","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: mortality remains increased in Cushing\u2019s disease despite biochemical remission: a systematic review and meta-analysis","volume":"172","author":"van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2018.02.005_bib28","unstructured":"Pivonello R, Vitale P, Mantovani L, et\u00a0al. MISSION STUDY. A worldwide epidemiological study on the mortality associated with Cushing\u2019s syndrome performed in nearly 5000 patients. 2013. Available at: http:\/\/www.endocrine.org\/meetings\/endo-annual-meetings\/abstract-details?ID=9808. Accessed October 27, 2017."},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib29","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and cardiovascular risk markers after remission of Cushing\u2019s disease: a prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.005_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cen.13230","article-title":"Proinflammatory cytokines remain elevated despite long-term remission in Cushing\u2019s disease: a prospective study","volume":"86","author":"Shah","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.005_bib31","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.005_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12020-016-0984-8","article-title":"Cushing\u2019s disease: the burden of illness","volume":"56","author":"Pivonello","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.005_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11102-007-0083-1","article-title":"Mortality following pituitary radiotherapy","volume":"12","author":"Ayuk","year":"2009","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.005_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/jcem-22-7-693","article-title":"Cause of Cushing\u2019s syndrome in patients with tumors arising from \u201cnonendocrine\u201d tissue","volume":"22","author":"Meador","year":"1962","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib35","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00464-011-2020-7","article-title":"Endoscopic bilateral adrenalectomy in patients with ectopic Cushing\u2019s syndrome","volume":"26","author":"Alberda","year":"2012","journal-title":"Surg Endosc"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.005_bib36","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.arcmed.2006.05.015","article-title":"Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor","volume":"37","author":"Hern\u00e1ndez","year":"2006","journal-title":"Arch Med Res"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.005_bib37","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00268-001-0032-5","article-title":"Cushing syndrome due to ectopic adrenocorticotropic hormone secretion","volume":"25","author":"Aniszewski","year":"2001","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.005_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2265.1986.tb01667.x","article-title":"Diagnosis and management of ACTH-dependent Cushing\u2019s syndrome: comparison of the features in ectopic and pituitary ACTH production","volume":"24","author":"Howlett","year":"1986","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.005_bib40","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.ecl.2018.02.005_bib41","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1002\/cncr.26029","article-title":"Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience","volume":"117","author":"Ejaz","year":"2011","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.005_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4158\/EP161677.OR","article-title":"Ectopic Cushing syndrome: a 10-year experience from a tertiary care center in Southern India","volume":"23","author":"Sathyakumar","year":"2017","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib43","first-page":"1088","article-title":"Long-term outcome of bilateral adrenalectomy in patients with Cushing\u2019s syndrome","volume":"116","author":"O\u2019Riordain","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.ecl.2018.02.005_bib44","first-page":"281","article-title":"Cushing\u2019s syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib45","first-page":"2051","article-title":"Cleveland clinic experience with adrenal Cushing\u2019s syndrome","volume":"158","author":"Daitch","year":"1997","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.005_bib46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1590\/S0004-27302007000800021","article-title":"Role for laparoscopic adrenalectomy in patients with Cushing\u2019s syndrome","volume":"51","author":"Young","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF03347198","article-title":"Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients","volume":"28","author":"Iacobone","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing\u2019s syndrome","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib50","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2265.2003.01881.x","article-title":"Management of adrenocortical carcinoma","volume":"60","author":"Allolio","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib52","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00268-010-0532-2","article-title":"Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma","volume":"34","author":"Miller","year":"2010","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.005_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"23","key":"10.1016\/j.ecl.2018.02.005_bib54","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.005_bib55","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: outcome of bilateral adrenalectomy in Cushing\u2019s syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"12","key":"10.1016\/j.ecl.2018.02.005_bib57","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib58","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.005_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3803\/EnM.2013.28.1.20","article-title":"Clinical characteristics for 348 patients with adrenal incidentaloma","volume":"28","author":"Kim","year":"2013","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.suc.2004.01.001","article-title":"Subclinical Cushing\u2019s syndrome in adrenal incidentalomas","volume":"84","author":"Sippel","year":"2004","journal-title":"Surg Clin North Am"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.005_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ecl.2005.01.008","article-title":"Subclinical Cushing\u2019s syndrome in adrenal incidentalomas","volume":"34","author":"Terzolo","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib62","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2010-2722","article-title":"Clinical review: diagnosis and treatment of subclinical hypercortisolism","volume":"96","author":"Chiodini","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.005_bib63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-016-1017-3","article-title":"Six controversial issues on subclinical Cushing\u2019s syndrome","volume":"56","author":"Chiodini","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.005_bib64","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib65","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study","volume":"166","author":"Di Dalmazi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.005_bib66","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanov\u00e0","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib67","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/jc.2012-4276","article-title":"Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma","volume":"98","author":"Debono","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.005_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.005_bib69","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.005_bib70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/hr.2011.90","article-title":"Clinical outcome of subclinical Cushing\u2019s syndrome after surgical and conservative treatment","volume":"34","author":"Akaza","year":"2011","journal-title":"Hypertens Res"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.005_bib72","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.005_bib73","doi-asserted-by":"crossref","first-page":"e60984","DOI":"10.1371\/journal.pone.0060984","article-title":"Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study","volume":"8","author":"Debono","year":"2013","journal-title":"PLoS One"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918300136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918300136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:17Z","timestamp":1760175797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852918300136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0889852918300136"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2018.02.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality in Patients with Endogenous Cushing\u2019s Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}